# β-lactam antibiotics: An overview from a medicinal chemistry perspective.

@article{Lima2020lactamAA,
title={$\beta$-lactam antibiotics: An overview from a medicinal chemistry perspective.},
author={L{\'i}dia Moreira Lima and Bianca Nascimento Monteiro da Silva and Gisele Barbosa and Eliezer Jesus Barreiro},
journal={European journal of medicinal chemistry},
year={2020},
volume={208},
pages={
112829
}
}
• L. M. Lima, +1 author E. Barreiro
• Published 16 September 2020
• Medicine, Chemistry
• European journal of medicinal chemistry
β-Lactam antibiotics are one of the most relevant drug classes of antibacterial agents worldwide. The discovery and the market of first β-lactam antibiotic (Penicillin G) is a symbolic landmark of modern chemotherapy. Since then, several other β-lactam antibiotics have been introduced in the therapy, revolutionizing the treatment of bacterial infections. Their antibacterial efficacy has been kept in check by the emergence of bacterial resistance. Among the resistance mechanisms, the expression… Expand
29 Citations
Interaction Mode of the Novel Monobactam AIC499 Targeting Penicillin Binding Protein 3 of Gram-Negative Bacteria
This report focuses on the interaction of the innovative β-lactam antibiotic AIC499 with penicillin binding protein 3 (PBP3) from Escherichia coli and Pseudomonas aeruginosa, and analyzes crystal structures of the respective complexes to explore the binding mode of Aic499 to its target proteins. Expand
Rapid Detection of Multiple Classes of β-Lactam Antibiotics in Blood Using an NDM-1 Biosensing Assay
• Qinglai Meng, Yao Wang, +9 authors Bin Xie
• Medicine
• Antibiotics
• 2021
The NDM-1 biosensor was able to quantify multiple classes of β-lactam antibiotics in blood plasma at concentrations ranging from 6.25 mg/L or 12.5mg/L, which covered the therapeutic concentration windows of the tested antibiotics used to treat critically ill patients. Expand
The Case against Antibiotics and for Anti-Virulence Therapeutics
Examples of potential anti-virulence targets and strategies that could be developed into bacterial infection treatments are discussed: the bacterial type III secretion system, quorum sensing, and liposomes. Expand
Isolation of Group A Streptococci with Reduced In Vitro β-Lactam Susceptibility Harboring Amino Acid Substitutions in Penicillin-Binding Proteins in Japan
• Tsubasa Ikeda, Wanchun Jin, Kouji Kimura
• Medicine
• Antimicrobial agents and chemotherapy
• 2021
The first isolation of Streptococcus pyogenes possessing the PBP2X substitution conferring reduced in vitro β-lactam susceptibility in Asia is reported, however, the MICs were below the susceptible breakpoint of the CLSI. Expand
Anti-infective dyes in the time of COVID
This perspective reflects both the background utility of antimicrobial dyes and ways forward for their inclusion in 21st Century infection control protocols. Expand
Pharmaceutical Approaches on Antimicrobial Resistance: Prospects and Challenges
The emergence of AMR is discussed and the importance of addressing this issue by discovering novel synthetic or naturally occurring antibacterial compounds and providing insights into the application of various drug delivery approaches, delivered through numerous routes, in comparison with conventional delivery systems is argued. Expand
Drugs That Changed Society: History and Current Status of the Early Antibiotics: Salvarsan, Sulfonamides, and β-Lactams
Development of salvarsan, sulfonamides, and β-lactams into efficient drugs is described and the effects on life expectancy and life quality of these new drugs are indicated. Expand
Marine Anticancer Agents: An Overview with a Particular Focus on Their Chemical Classes
This review focuses on the bioactive molecules derived from the marine environment with anticancer activity, discussing their families, origin, structural features and therapeutic use. Expand
Antibacterial Activities of Homemade Matrices Miming Essential Oils Compared to Commercial Ones
GC–MS analysis revealed that thyme essential oils have a chemical composition far more consistent than ajowan essential oils, and the benefits of using a complex chemical mixture instead of one active compound to fight bacterial resistance are questioned. Expand
A Natural Alternative Treatment for Urinary Tract Infections: Itxasol©, the Importance of the Formulation
• Medicine
• Molecules
• 2021
The objective is to review the characteristics of the compounds of a new formulation called Itxasol© that is prescribed as an adjuvant for the treatment of UTIs and composed of β-arbutin, umbelliferon and n-acetyl cysteine, which makes ItxAsol© a broad-spectrum antibiotic with bactericidal, bacteriostatic and antifungal properties. Expand

#### References

SHOWING 1-10 OF 258 REFERENCES
β-Lactam Antibiotics
• Biology
• 2009
Analysis of the enzymes involved in the biosynthesis of these compounds and the genes encoding them reveals interesting patterns of gene conservation and at the same time shows novel genes that have been recruited into the β-lactam gene clusters during evolution, leading to the formation of bizarre chemical structures. Expand
New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
• Medicine, Biology
• Antimicrobial Agents and Chemotherapy
• 2013
This “renaissance” of β-lactamase inhibitors offers new hope in a world plagued by multidrug-resistant (MDR) Gram-negative bacteria. Expand
• Chemistry, Biology
• Clinical Microbiology Reviews
• 2010
The mechanisms of action and salient clinical and microbiological features of β-lactamase inhibitors are highlighted and novel compounds and the chemical features of these agents that may contribute to a “second generation” of inhibitors are focused on. Expand
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
It is contended that issues including continuing unresolved questions around mechanism; opportunities afforded by new technologies such as serial femtosecond crystallography; the need for new inhibitors, particularly for MBLs; the likely impact of new β-lactam:inhibitor combinations and the continuing clinical importance of β- lactams mean that this remains a rewarding research area. Expand
Class A β-lactamases—enzyme-inhibitor interactions and resistance
• Chemistry
• 1999
Abstract β-Lactamases of Ambler's Class A are the most commonly encountered mechanism of bacterial resistance to β-lactam antibiotics. In the face of selective pressure arising from use of eitherExpand
Elucidating the Molecular Basis of Avibactam Mediated Inhibition of Class A β-Lactamases.
• Medicine, Chemistry
• Chemistry
• 2020
While unraveling the reasons behind the inhibition of all the deacylation routes, this study explains various experimental structural and kinetics data, and proposes a way to design new inhibitors based on the β-lactam framework. Expand
Understanding the longevity of the β-lactam antibiotics and of antibiotic/β-lactamase inhibitor combinations
It is likely that resistance problems will eventually threaten these new products and it may be instructive to review the successful employment of β-lactam antibiotic/β- lactamase inhibitor combinations to combat penicillin resistance. Expand
Inhibitors of metallo-β-lactamases.
• Biology, Medicine
• Current opinion in microbiology
• 2017
The increase in the number of candidate MBL inhibitors over recent years reflects the growing clinical challenge of pathogens expressing these enzymes that result in a carbapenem resistance phenotype and there is a strong incentive to continue identifying and characterizing such molecules. Expand
Molecular analysis of beta-lactamase structure and function.
• Biology, Medicine
• International journal of medical microbiology : IJMM
• 2002
In this review, the recent work performed on the four different classes (A, B, C, and D) of beta-lactamases are discussed and investigative advances further expand knowledge about these complex enzymes, and hopefully, will provide us with additional tools to develop new inhibitors and antibiotics based on structural and rational designs. Expand
Faropenem daloxate: Penem antibiotic
• Biology
• 2002
The penem faropenem has been developed and shown to have excellent activity against a wide range of bacteria, including extended-spectrum β-lactamase (ESBL)-producing strains, and was selected for clinical development in the treatment of community-acquired respiratory tract infections. Expand